Abstract:OBJECTIVE:Mitochondrial disease is a group of energy metabolic disorders, characterized by involvement of multisystem with high energy requirements. Encephalomyopathies are common clinical findings of the mitochondrial diseases. However, mitochondrial cardiac damage is not rare. In this study, the clinical, biological, and genetic analyses were performed in three patients with mitochondrial cardiac damage, in order to understand the characteristics of mitochondrial diseases.METHOD:Three girls presented with arrhythmia and cardiac enlargement from the age of 3, 4 and 8 years respectively. They were admitted into the Peking University First Hospital. Infection, autoimmune diseases, aminoacidopathies, organic acidurias, mitochondrial-fatty acid oxidation defects, and lysosomal storage disease were excluded by routine laboratory examinations and metabolic analysis for blood amino acids, acylcarnitines, urinary organic acids, and lysosome activity assay. Peripheral leukocytes mitochondrial respiratory chain enzyme I to V activities were measured by spectrophotometry. The entire sequence of the mitochondrial DNA was analyzed.RESULT:In two patients (case 1 and case 3), hypertrophic cardiomyopathy and grade I to grade II of cardiac function were found. One patient (case 2) was diagnosed with arrhythmia and grade I of cardiac function. Increased creatine phosphokinase and creatine kinase isoenzyme MB were observed. Mitochondrial respiratory chain complex deficiencies were indentified in the three patients. Patient 1 had combined deficiencies of complex III and V. The activity of complex I+III was 18.7 nmol/(min·mg mitochondrial protein) (control 84.4 ± 28.5). The activity of complex V was 20.4 nmol/(min·mg mitochondrial protein) (control 103.7 ± 29.2). In her mitochondrial gene, A14693G on tRNA(Glu) and T16519C on D-loop were found. Patient 2 had an isolated complex I deficiency. The activity was 22.0 nmol/(min·mg mitochondrial protein) (control 44.0 ± 5.4). A16183C, T16189C and G15043A mutations on D-loop were found. Patient 3 had a combined deficiency of complex IV and V. The activity of complex IV was 21.0 nmol/(min·mg mitochondrial protein) (control 54.1 ± 12.3). The activity of complex V was 23.2 nmol/(min·mg mitochondrial protein) (control 103.7 ± 29.2). C253T and C16187T mutations on D-loop were detected. Haplotype analysis showed that three patients belong to H2a2a. Improvement was observed after the treatment with L-carnitine, coenzyme Q10, vitamin C and E. At present, the patients are 7, 5 and 8 years old. Although excise intolerance still persists, they had a good general condition with normal school life.CONCLUSION:The mitochondrial diseases with cardiac damage show cardiomyopathy, arrhythmia and exercise intolerance. Many kinds of mitochondrial respiratory chain deficiency were observed. A14693G in mitochondrial tRNA(Glu) gene is probably one of the causes in China.

Pulmonary Hypertension As a Manifestation of Mitochondrial Disease

Mitochondrial dysfunction in pulmonary arterial hypertension

Mitochondrial dysfunction and pulmonary hypertension: cause, effect, or both.

The Novel Mitochondrial 16S Rrna 2336T>C Mutation is Associated with Hypertrophic Cardiomyopathy

The mitochondrial function of mitochondrial tRNAMet4435A＞G mutation combined with YARS2 c.5750A＞C mutation associated with essential hypertension?

Systematic Analysis of the Clinical and Biochemical Characteristics of Maternally Inherited Hypertension in Chinese Han Families Associated with Mitochondrial

Mitochondrial Trna Mutations in Chinese Hypertensive Individuals

Therapeutic and tampering approaches for mitochondrial associated diseases

Mitochondria in hypoxic pulmonary hypertension, roles and the potential targets

Mutations in mitochondrial DNA associated with hypertension]

Mitochondrial Biogenesis Dysfunction and Metabolic Dysfunction from A Novel Mitochondrial Trna(Met) 4467 C > A Mutation in A Han Chinese Family with Maternally Inherited Hypertension

Acquired disorders of mitochondrial metabolism and dynamics in pulmonary arterial hypertension

Mitochondrial Metabolism, Redox, and Calcium Homeostasis in Pulmonary Arterial Hypertension

[Clinical, Biochemical and Genetic Analysis of the Mitochondrial Disorders Presenting with Cardiac Damage].

Hypoxia Promotes Pulmonary Vascular Remodeling Via HIF-1α to Regulate Mitochondrial Dynamics

Identifying Potential Mitochondrial Proteome Signatures Associated with the Pathogenesis of Pulmonary Arterial Hypertension in the Rat Model

Mitochondrial Dysfunctions Contribute to Hypertrophic Cardiomyopathy in Patient Ipsc-Derived Cardiomyocytes with MT-RNR2 Mutation.

Endocrine Manifestations and New Developments in Mitochondrial Disease

Emerging insights into pulmonary hypertension: the potential role of mitochondrial dysfunction and redox homeostasis

Reversible cardiac function and left ventricular hypertrophy in a Chinese man with mitochondrial myopathy: a case report

Clinical Profile and Outcome of Pediatric Mitochondrial Myopathy in China